首页|Yes关联蛋白1在食管鳞状细胞癌中的临床意义

Yes关联蛋白1在食管鳞状细胞癌中的临床意义

扫码查看
目的 探讨Yes关联蛋白 1(Yes-associated protein 1,YAP1)在食管鳞状细胞癌组织中的表达情况及临床意义.方法 采用免疫组化技术检测 439 例食管鳞状细胞癌患者癌组织中YAP1 的表达,分析YAP1 阳性组与阴性组患者的临床病理参数差异.采用Kaplan-Meier生存曲线分析YAP1 对患者生存的影响.结果 食管鳞状细胞癌中,YAP1 的阳性率为 30.52%(134/439).YAP1 阳性组患者肿瘤浸润更深(P<0.001).Kaplan-Meier生存曲线分析显示,在生存期长于 30 个月的患者中,YAP1 阳性者无瘤生存期(disease-free survival,DFS)和总生存期(overall survival,OS)更长(P<0.05).Cox多因素回归分析显示,浸润深度是影响患者DFS(HR=1.371,95%CI 0.993~1.894,P=0.035)和OS(HR=1.489,95%CI 1.066~2.080,P=0.020)的独立因素.结论 YAP1 在部分食管鳞状细胞癌中表达;对于生存期大于30个月的患者,YAP1表达阳性提示预后更好.
Clinical significance of Yes-associated protein 1 in esophageal squamous cell carcinoma
Objective To explore the expression and clinical significance of Yes-associated protein 1(YAP1)in esophageal squamous cell carcinoma.Methods Immunohistochemical method was used to detect YAP1 expression in 439 cases of esophageal squamous cell carcinoma.The differences of YAP1 expression and clinical parameters were analyzed between YAP1 positive group and YAP1 negative group.Kaplan-Meier curve was used to analyze the influence of YAP1 expression on survival of patients.Results The positive rate of YAP1 in esophageal squamous cell carcinoma was 30.52% .The tumor invasion was deeper in YAP1 positive group(P<0.001).Kaplan-Meier survival analysis showed that YAP1 positive patients had longer disease-free survival(DFS)and overall survival(OS)among patients surviving longer than 30 months(P<0.05).The multivariate Cox regression analysis showed that the invasion depth of tumor was an independent factor affecting DFS(HR=1.371,95% CI 0.993-1.894,P=0.035)and OS(HR=1.489,95% CI 1.066-2.080,P=0.020).Conclusions YAP1 has a certain percentage of positive rate in esophageal squamous cell carcinoma;for patients with survival longer than 30 months,YAP1 positive indicates a better prognosis.

esophageal squamous cell carcinomaYes-associated protein 1prognosis

刘坤、管瑛瑛、蒋冬先、许惠娟、侯英勇、侯君

展开 >

复旦大学附属中山医院厦门医院病理科,厦门 361015

福建省腹部肿瘤精准诊疗临床医学研究中心,厦门 361015

复旦大学附属中山医院病理科,上海 200032

食管鳞状细胞癌 Yes关联蛋白1 预后

福建省卫生健康科技计划项目厦门市医疗卫生指导性项目厦门市医疗卫生指导性项目复旦大学附属中山医院厦门医院院级孵化课题

2023QNB0113502Z20224ZD10893502Z20244ZD11252018ZSXMYJ01

2024

中国临床医学
复旦大学附属中山医院

中国临床医学

CSTPCD
影响因子:1.002
ISSN:1008-6358
年,卷(期):2024.31(5)